In Vitro Aging of Osteoblasts
Corresponding Organization : Kaohsiung Chang Gung Memorial Hospital
Other organizations : RWTH Aachen University, Maastricht University
Variable analysis
- Passage number of osteoblasts (primary vs. aged group)
- Treatment with 5-Aza-2'-deoxycystidine (5-aza)
- Treatment with N-acetylcysteine (NAC)
- Outcomes measured in osteoblasts (not explicitly mentioned)
- Passage 0 (P0) osteoblasts isolated from 3-month-old mice
- Incubation in DMEM and 10% FBS medium
- Incubation time (3 days for primary osteoblasts, 4 h for 5-aza and NAC treatments)
- Positive control: Not explicitly mentioned
- Negative control: Not explicitly mentioned
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!